Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib mesylate when the patent is expiring in india?Mebendazole ingredients?Norcuron generic name?How does paclitaxel's binding to albumin change its pharmacokinetics?What's the impact of mixing lipitor bp meds negatively?
See the DrugPatentWatch profile for shingrix
Shingrix is given as a 2-dose series for adults 50 years and older to prevent herpes zoster (shingles) and its complications. Each dose is 0.5 mL intramuscularly, with the second dose administered 2 to 6 months after the first.[1][2]
The CDC recommends Shingrix for: - Adults 50 years and older, regardless of prior shingles or vaccination history. - Adults 19 years and older who are or will be immunodecompromised (e.g., due to disease or therapy).[1][2] For immunocompromised adults, the second dose can be given as early as 1-2 months after the first.[1]
If more than 6 months pass before the second dose, it can still be given—no need to restart the series. Administer at the next opportunity.[1][2]
Inject 0.5 mL into the deltoid region of the upper arm, using a sterile needle and syringe. Shake well before use; do not use if discolored or particles are present.[2]
Store refrigerated at 36°F to 46°F (2°C to 8°C). Once reconstituted, use within 6 hours and discard unused portions.[2] [1]: CDC Shingrix VIS [2]: Shingrix Prescribing Information (GSK)
Other Questions About Shingrix :